Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma-Reference-Cited by-同舟云学术

Serum autoantibody to sideroflexin 3 as a novel tumor marker for oral squamous cell carcinoma

Published:2008-04 Issue:4 Volume:2 Page:517-527
ISSN:1862-8346
Container-title:PROTEOMICS – CLINICAL APPLICATIONS
language:en
Short-container-title:Prot. Clin. Appl.

Author:

Murase Ryuichi,Abe Yasuhito,Takeuchi Takashi,Nabeta Motowo,Imai Yoshinori,Kamei Yoshiaki,Kagawa-Miki Lisa,Ueda Norifumi,Sumida Tomoki,Hamakawa Hiroyuki,Kito Katusmi

Publisher

Wiley

Subject

Clinical Biochemistry

Reference36 articles.

1. Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma

2. Squamous cell carcinoma antigen in the diagnosis and treatment follow-up of oral and facial squamous cell carcinoma

3. An evaluation of squamous cell carcinoma antigen in patients with cervical squamous cell carcinoma

4. Clinical Assay of Serum SCC-Ag in Urothelial Cancers

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SFXN3 is a Prognostic Marker and Promotes the Growth of Acute Myeloid Leukemia;Cell Biochemistry and Biophysics;2024-06-14

2. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review);Oncology Reports;2023-10-20

3. SFXN3 is Associated with Poor Clinical Outcomes and Sensitivity to the Hypomethylating Therapy in Non-M3 Acute Myeloid Leukemia Patients;Current Gene Therapy;2023-10

4. Identification of iron metabolism-related genes as prognostic indicators for papillary thyroid carcinoma: a retrospective study;PeerJ;2023-06-21

5. Evaluation of clinical significances and anti-tumor effects with several prognostic factors in patients with acute myeloid leukemia;Journal of Radiation Research and Applied Sciences;2023-03